DCGI gives permission for approval of protocol for a multi-center two arm prospective, phase-II open labeled randomized controlled trial of convalescent plasma in COVID-19 patients.
source https://www.pharmatutor.org/pharma-news/2020/how-convalescent-plasma-therapy-helpful-in-covid-19
No comments:
Post a Comment